# CLOPIDOGREL BISULFATE
> **ANDA213351** · Abbreviated New Drug Application (Generic) · Sponsor: PURACAP LABS BLU · Approved 2020-07-17
## Drug
- **FDA Application Number:** ANDA213351
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOPIDOGREL BISULFATE
- **Generic name:** CLOPIDOGREL
- **Active ingredients:** CLOPIDOGREL BISULFATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PURACAP LABS BLU
- **Manufacturer:** POLYGEN PHARMACEUTICALS INC.
- **First approval:** 2020-07-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213351)
---
*MORVS · CC0 1.0*